Stemgent Inc., a Cambridge, Mass.-based provider of stem cell technologies and research tools, has raised $14 million in Series A-1 funding, according to a regulatory filing. Backers include HealthCare Ventures and Morgenthaler Ventures. www.stemgent.com
Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!